丽珠集团：拟15.87亿元收购越南IMP公司64.81%股份

Core Viewpoint - Lijuz Group plans to acquire a 64.81% stake in Imexpharm Corporation from SK Investment Vina III Pte.Ltd., Sunrise Kim Investment Joint Stock Company, and KBA Investment Joint Stock Company for approximately 15.87 billion RMB [1] Group 1 - The acquisition price is set at 57,308.15 billion Vietnamese Dong, which is equivalent to about 15.87 billion RMB based on the exchange rate on the date of the agreement [1] - The transaction will not be classified as a related party transaction and does not constitute a major asset restructuring as defined by the regulations [1] - Following the completion of the transaction, Imexpharm Corporation will become a subsidiary included in Lijuz Group's consolidated financial statements [1]